Latest News about covid/19 vaccine
Recent news which mentions covid/19 vaccine
From Benzinga
Britain Study Shows Restricted Use Of AstraZeneca COVID-19 Shot Associated With No Clot Cases: Reuters
August 12, 2021
From Benzinga
Why Moderna Stock Is Continuing Its Losses Today
August 11, 2021
From Benzinga
Will Kidney Transplant Recipients Need Third COVID-19 Vaccine Dose? NIH Starts Pilot Study
August 10, 2021
From Benzinga
From Benzinga
From Benzinga
BioNTech Records Stupendous Q2 Sales, Earnings Growth; Estimates FY21 COVID-19 Vaccine Revenues Of €15B
August 09, 2021
From Benzinga
Aerogami addresses public concerns over data privacy with vaccine credential technology, DigiVaxDoc
August 06, 2021
From PRUnderground
From Benzinga
From Benzinga
Combining AstraZeneca, mRNA COVID-19 Vaccines Show Efficacy In Danish Study: Reuters
August 02, 2021
From Benzinga
Arcturus' COVID-19 mRNA Vaccine Candidate To Target Variants, Trial To Start In Vietnam
August 02, 2021
Tickers
ARCT
From Benzinga
Vaxart Stock Is Trading Higher As FDA Clears Mid-Stage Trial For S-Only Oral COVID-19 Vaccine Candidate
August 02, 2021
Tickers
VXRT
From Benzinga
Arcturus Therapeutics Stock Jumps On Establishment Of COVID-19 Vaccine Plant In Vietnam
August 02, 2021
Tickers
ARCT
From Benzinga
Johnson & Johnson Pulls Application For Accelerated Approval Of COVID-19 Shot In India: Report
August 02, 2021
From Benzinga
Cashing COVID-19 Vaccine - AstraZeneca Or Pfizer
July 29, 2021
From Benzinga
Vaxart Stock Shoots Higher After Its Oral Vaccine Boosts Immune Response In Previously Vaccinated Subject
July 29, 2021
Tickers
VXRT
From Benzinga
Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant
July 29, 2021
From Benzinga
From Benzinga
AstraZeneca Stock Gains As Q2 Earnings Beat Forecasts, Clocks $894M In COVID-19 Vaccine Sales
July 29, 2021
From Benzinga
From Benzinga
No Increased Risk Of Blood Clots After Second Dose Of AstraZeneca's COVID-19 Shot, Study Shows
July 28, 2021
Tickers
AZN
From Benzinga
From Benzinga
Pfizer Q2 Results Beat Wall Street Expectations; Expects $33B From COVID-19 Vax Sales In 2021
July 28, 2021
Tickers
PFE
From Benzinga
Dyadic Stock Shoots Higher On Technology Transfer, Licensing Pact For COVID-19 Vaccine In African Continent
July 27, 2021
Tickers
DYAI
From Benzinga
Oragenics Stock Is Trading Higher On Licensing, Material Transfer Pact For Rapid Development Of COVID-19 Vaccine
July 27, 2021
Tickers
OGEN
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.